Cysteinyl leukotrienes: multi‐functional mediators in allergic rhinitis

Abstract

Summary Cysteinyl leukotrienes (CysLTs) are a family of inflammatory lipid mediators synthesized from arachidonic acid by a variety of cells, including mast cells, eosinophils, basophils, and macrophages. This article reviews the data for the role of CysLTs as multi‐functional mediators in allergic rhinitis (AR). We review the evidence that: (1) CysLTs are released from inflammatory cells that participate in AR, (2) receptors for CysLTs are located in nasal tissue, (3) CysLTs are increased in patients with AR and are released following allergen exposure, (4) administration of CysLTs reproduces the symptoms of AR, (5) CysLTs play roles in the maturation, as well as tissue recruitment, of inflammatory cells, and (6) a complex inter‐regulation between CysLTs and a variety of other inflammatory mediators exists.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 206

1. 1.

   Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999;104:301-4.

   Not in our library10.1016/s0091-6749(99)70370-2

2. 2.

   Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171-83.

   Not in our library10.1067/mai.2003.1592

3. 3.

   Murphy RC, Hammarstrom S, Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA. 1979;76:4275-9.

   Not in our library10.1073/pnas.76.9.4275

4. 4.

   Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999;340:197-206.

   Not in our library10.1056/nejm199901213400306

5. 5.

   Mita H, Hasegawa M, Saito H, Akiyama K. Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils. Clin Exp Allergy. 2001;31:1714-23.

   Not in our library10.1046/j.1365-2222.2001.01184.x

6. 6.

   Mellor EA, Frank N, Soler D, et al. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R. Proc Natl Acad Sci USA. 2003;100:11589-93.

   Not in our library10.1073/pnas.2034927100

7. 7.

   Gauvreau GM, Boulet LP, Postma DS, et al. Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma. J Allergy Clin Immunol. 2005;116:285-91.

   Not in our library10.1016/j.jaci.2005.05.021

8. 8.

   Steinke JW, Borish L. Leukotriene receptors in rhinitis and sinusitis. Curr Allergy Asthma Rep. 2004;4:217-23.

   Not in our library10.1007/s11882-004-0029-x

9. 9.

   Borish L. Allergic rhinitis: systemic inflammation and implications for management. J Allergy Clin Immunol. 2003;112:1021-31.

   Not in our library10.1016/j.jaci.2003.09.015

10. 10.

    Corrigan C, Mallett K, Ying S, et al. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol. 2005;115:316-22.

    Not in our library10.1016/j.jaci.2004.10.051

11. 11.

    Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399:789-93.

    Not in our library10.1038/21658

12. 12.

    Eglite S, Pluss K, Dahinden CA. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils. J Immunol. 2000;165:2183-9.

    Not in our library10.4049/jimmunol.165.4.2183

13. 13.

    Takafuji S. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluable agonists. J Immunol. 1991;147:3855-61.

    Not in our library

14. 14.

    Kohi F, Miyagawa H, Agrawal DK, Bewtra AK, Townley RG. Generation of leukotriene B4 and C4 from granulocytes of normal controls, allergic rhinitis, and asthmatic subjects. Ann Allergy. 1990;65:228-32.

    Not in our library

15. 15.

    Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy. 2003;33:1380-8.

    Not in our library10.1046/j.1365-2222.2003.01786.x

16. 16.

    Shirasaki H, Kanaizumi E, Watanabe K, et al. Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy. 2002;32:1007-12.

    Not in our library10.1046/j.1365-2222.2002.01425.x

17. 17.

    Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med. 2001;163:226-33.

    Not in our library10.1164/ajrccm.163.1.2003101

18. 18.

    Mellor EA, Maekawa A, Austen KF, Boyce JA. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA. 2001;98:7964-9.

    Not in our library10.1073/pnas.141221498

19. 19.

    Bautz F, Denzlinger C, Kanz L, Mohle R. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor cyslt1. Blood. 2001;97:3433-40.

    Not in our library10.1182/blood.v97.11.3433

20. 20.

    Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347:1524-6.

    Not in our library10.1056/nejmoa013508

21. 21.

    Thivierge M, Stankova J, Rola-Pleszczynski M. IL-13 and IL-14 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol. 2001;167:2855-60.

    Not in our library10.4049/jimmunol.167.5.2855

22. 22.

    Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol. 1980;66:82-8.

    Not in our library10.1016/0091-6749(80)90143-8

23. 23.

    Beller TC, Maekawa A, Friend DS, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem. 2004;279:46129-34.

    Not in our library10.1074/jbc.m407057200

24. 24.

    Hui Y, Cheng Y, Smalera I, et al. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation. 2004;110:3360-6.

    Not in our library10.1161/01.cir.0000147775.50954.aa

25. 25.

    Maekawa A, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem. 2002;277:20820-9.

    Not in our library10.1074/jbc.m203163200

26. 26.

    Beller TC, Friend DS, Maekawa A, Lam BK, Austen KF, Kanaoka Y. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci USA. 2004;101:3047-52.

    Not in our library10.1073/pnas.0400235101

27. 27.

    Knani J, Campbell A, Enander I, Peterson CG, Michel FB, Bousquet J. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol. 1992;90:880-9.

    Not in our library10.1016/0091-6749(92)90460-j

28. 28.

    Kojima T, Asakura K. A study of chemical mediators in patients with allergic rhinitis. 3. Release of histamine and leukotrienes from in vitro nasal mucosa. Nippon Jibiinkoka Gakkai Kaiho. 1991;94:587-93.

    Not in our library10.3950/jibiinkoka.94.587

29. 29.

    de Graaf-in't Veld, Garrelds IM, Koenders S, Gerth VW. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls. Clin Exp Allergy. 1996;26:903-8.

    Not in our library

30. 30.

    Creticos PS, Peters SP, Adkinson NF, et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984;310:1626-30.

    Not in our library10.1056/nejm198406213102502

31. 31.

    Miadonna A, Tedeschi A, Leggieri E, et al. Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis. 1987;136:357-62.

    Not in our library10.1164/ajrccm/136.2.357

32. 32.

    Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987;316:1506-10.

    Not in our library10.1056/nejm198706113162403

33. 33.

    Wang D, Clement P, Smitz J, De Waele M, Derde MP. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol. 1995;106:278-85.

    Not in our library10.1159/000236855

34. 34.

    Shaw RJ, Fitzharris P, Cromwell O, Wardlaw AJ, Kay AB. Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Allergy. 1985;40:1-6.

    Not in our library10.1111/j.1398-9995.1985.tb04147.x

35. 35.

    Ophir D, Fink A, Eliraz A, Tabachnik E, Bentwich Z. Allergen-induced leukotriene production by nasal mucosa and peripheral blood leukocytes. Arch Otolaryngol Head Neck Surg. 1988;114:522-4.

    Not in our library10.1001/archotol.1988.01860170052017

36. 36.

    Skoner DP, Lee L, Doyle WJ, Boehm S, Fireman P. Nasal physiology and inflammatory mediators during natural pollen exposure. Ann Allergy. 1990;65:206-10.

    Not in our library

37. 37.

    Volovitz B, Osur SL, Bernstein JM, Ogra PL. Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children. J Allergy Clin Immunol. 1988;82:414-8.

    Not in our library10.1016/0091-6749(88)90000-0

38. 38.

    Togias AG, Naclerio RM, Peters SP, et al. Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis. 1986;133:1133-7.

    Not in our library10.1164/arrd.1986.133.6.1133

39. 39.

    Machida I, Matsuse H, Kondo Y, et al. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol. 2004;172:1833-8.

    Not in our library10.4049/jimmunol.172.3.1833

40. 40.

    Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O'Byrne PM. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol. 2004;114:73-9.

    Not in our library10.1016/j.jaci.2004.03.054

Cited by papers we hold 2

• Allergic Rhinitis: A Clinical and Pathophysiological Overview · 2022
  No notice
• The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.